GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Mani Inc (OTCPK:MNICF) » Definitions » Debt-to-EBITDA

Mani (MNICF) Debt-to-EBITDA : 0.02 (As of Aug. 2024)


View and export this data going back to 2011. Start your Free Trial

What is Mani Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

Mani's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Aug. 2024 was $0.3 Mil. Mani's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Aug. 2024 was $0.3 Mil. Mani's annualized EBITDA for the quarter that ended in Aug. 2024 was $35.6 Mil. Mani's annualized Debt-to-EBITDA for the quarter that ended in Aug. 2024 was 0.02.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Mani's Debt-to-EBITDA or its related term are showing as below:

MNICF' s Debt-to-EBITDA Range Over the Past 10 Years
Min: 0.01   Med: 0.01   Max: 0.02
Current: 0.01

During the past 13 years, the highest Debt-to-EBITDA Ratio of Mani was 0.02. The lowest was 0.01. And the median was 0.01.

MNICF's Debt-to-EBITDA is ranked better than
99.77% of 429 companies
in the Medical Devices & Instruments industry
Industry Median: 1.54 vs MNICF: 0.01

Mani Debt-to-EBITDA Historical Data

The historical data trend for Mani's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mani Debt-to-EBITDA Chart

Mani Annual Data
Trend Aug15 Aug16 Aug17 Aug18 Aug19 Aug20 Aug21 Aug22 Aug23 Aug24
Debt-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.01 0.02 0.01 0.01 0.01

Mani Quarterly Data
Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24
Debt-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.01 - 0.01 0.01 0.02

Competitive Comparison of Mani's Debt-to-EBITDA

For the Medical Instruments & Supplies subindustry, Mani's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Mani's Debt-to-EBITDA Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Mani's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Mani's Debt-to-EBITDA falls into.



Mani Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Mani's Debt-to-EBITDA for the fiscal year that ended in Aug. 2024 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(0.267 + 0.301) / 73.155
=0.01

Mani's annualized Debt-to-EBITDA for the quarter that ended in Aug. 2024 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(0.267 + 0.301) / 35.552
=0.02

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Aug. 2024) EBITDA data.


Mani  (OTCPK:MNICF) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


Mani Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Mani's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Mani Business Description

Traded in Other Exchanges
Address
8-3 Kogyodanchi, Tochigi, JPN
Mani Inc manufactures medical devices and dental instruments. It sells products in four categories: surgical instruments, ophthalmic instruments, suture needles, and dental instruments. Mani's surgical products include instruments such as staplers, vessel knives, and bone saws. Its ophthalmic instruments include a range of knives used during eye surgery and ophthalmic sutures. Mani's suture needles business includes a variety of taper point and cutting eyeless needles, which require suture attachment and sterilization by the customer, as well as stainless-steel eyed needles. The firm's dental instruments include endodontic instruments and accessories, root canal equipment, and finishing and polishing instruments.

Mani Headlines

From GuruFocus

Hennessy Japan Fund Top Q3 Stock Adds and Reductions

By Holly LaFon Holly LaFon 10-04-2014